COCA-COLA CONSOLIDATED INC (COKE) Fundamental Analysis & Valuation

NASDAQ:COKE • US1910981026

Current stock price

205.21 USD
+2.85 (+1.41%)
Last:

This COKE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. COKE Profitability Analysis

1.1 Basic Checks

  • In the past year COKE was profitable.
  • COKE had a positive operating cash flow in the past year.
  • Each year in the past 5 years COKE has been profitable.
  • COKE had a positive operating cash flow in each of the past 5 years.
COKE Yearly Net Income VS EBIT VS OCF VS FCFCOKE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.26%, COKE belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 22.12%, COKE belongs to the top of the industry, outperforming 97.06% of the companies in the same industry.
  • COKE had an Average Return On Invested Capital over the past 3 years of 19.46%. This is significantly above the industry average of 11.81%.
  • The 3 year average ROIC (19.46%) for COKE is below the current ROIC(22.12%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.26%
ROE N/A
ROIC 22.12%
ROA(3y)11.57%
ROA(5y)10.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.46%
ROIC(5y)17.54%
COKE Yearly ROA, ROE, ROICCOKE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

1.3 Margins

  • The Profit Margin of COKE (7.89%) is comparable to the rest of the industry.
  • COKE's Profit Margin has improved in the last couple of years.
  • The Operating Margin of COKE (13.15%) is comparable to the rest of the industry.
  • COKE's Operating Margin has improved in the last couple of years.
  • COKE has a Gross Margin (39.74%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of COKE has grown nicely.
Industry RankSector Rank
OM 13.15%
PM (TTM) 7.89%
GM 39.74%
OM growth 3Y8.36%
OM growth 5Y15.89%
PM growth 3Y4.4%
PM growth 5Y18.04%
GM growth 3Y2.65%
GM growth 5Y2.36%
COKE Yearly Profit, Operating, Gross MarginsCOKE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. COKE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so COKE is creating value.
  • The number of shares outstanding for COKE has been reduced compared to 1 year ago.
  • The number of shares outstanding for COKE has been reduced compared to 5 years ago.
  • Compared to 1 year ago, COKE has a worse debt to assets ratio.
COKE Yearly Shares OutstandingCOKE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
COKE Yearly Total Debt VS Total AssetsCOKE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • An Altman-Z score of 3.83 indicates that COKE is not in any danger for bankruptcy at the moment.
  • COKE's Altman-Z score of 3.83 is fine compared to the rest of the industry. COKE outperforms 73.53% of its industry peers.
  • COKE has a debt to FCF ratio of 4.50. This is a neutral value as COKE would need 4.50 years to pay back of all of its debts.
  • The Debt to FCF ratio of COKE (4.50) is better than 73.53% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.5
Altman-Z 3.83
ROIC/WACC2.73
WACC8.1%
COKE Yearly LT Debt VS Equity VS FCFCOKE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B

2.3 Liquidity

  • COKE has a Current Ratio of 1.26. This is a normal value and indicates that COKE is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.26, COKE perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
  • A Quick Ratio of 0.97 indicates that COKE may have some problems paying its short term obligations.
  • COKE has a Quick ratio of 0.97. This is in the better half of the industry: COKE outperforms 61.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.97
COKE Yearly Current Assets VS Current LiabilitesCOKE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. COKE Growth Analysis

3.1 Past

  • The earnings per share for COKE have decreased by -2.92% in the last year.
  • Measured over the past years, COKE shows a very strong growth in Earnings Per Share. The EPS has been growing by 137.97% on average per year.
  • Looking at the last year, COKE shows a small growth in Revenue. The Revenue has grown by 4.76% in the last year.
  • COKE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.41% yearly.
EPS 1Y (TTM)-2.92%
EPS 3Y185.54%
EPS 5Y137.97%
EPS Q2Q%-88.35%
Revenue 1Y (TTM)4.76%
Revenue growth 3Y7.44%
Revenue growth 5Y7.41%
Sales Q2Q%9.03%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
COKE Yearly Revenue VS EstimatesCOKE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
COKE Yearly EPS VS EstimatesCOKE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2024 20 40 60

More info and screens

Find the best growth stocksShow best growing peers

4

4. COKE Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 2.74 indicates a rather cheap valuation of COKE.
  • Based on the Price/Earnings ratio, COKE is valued cheaper than 97.06% of the companies in the same industry.
  • COKE is valuated cheaply when we compare the Price/Earnings ratio to 26.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.74
Fwd PE N/A
COKE Price Earnings VS Forward Price EarningsCOKE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as COKE.
  • Based on the Price/Free Cash Flow ratio, COKE is valued a bit cheaper than the industry average as 64.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 22.04
EV/EBITDA 13.66
COKE Per share dataCOKE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

  • COKE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.02
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. COKE Dividend Analysis

5.1 Amount

  • COKE has a yearly dividend return of 0.55%, which is pretty low.
  • Compared to an average industry Dividend Yield of 1.83, COKE has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.55, COKE pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

  • The dividend of COKE has a limited annual growth rate of 3.68%.
  • COKE has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)3.68%
Div Incr Years0
Div Non Decr Years0
COKE Yearly Dividends per shareCOKE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • COKE pays out 15.19% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of COKE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP15.19%
EPS Next 2YN/A
EPS Next 3YN/A
COKE Yearly Income VS Free CF VS DividendCOKE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M
COKE Dividend Payout.COKE Dividend Payout, showing the Payout Ratio.COKE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

COKE Fundamentals: All Metrics, Ratios and Statistics

COCA-COLA CONSOLIDATED INC

NASDAQ:COKE (4/9/2026, 11:14:49 AM)

205.21

+2.85 (+1.41%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-18
Earnings (Next)04-28
Inst Owners68.29%
Inst Owner Change0%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap13.66B
Revenue(TTM)7.23B
Net Income(TTM)570.58M
Analysts43.33
Price TargetN/A
Short Float %2.57%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend1.2
Dividend Growth(5Y)3.68%
DP15.19%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-23
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.74
Fwd PE N/A
P/S 1.89
P/FCF 22.04
P/OCF 14.66
P/B N/A
P/tB N/A
EV/EBITDA 13.66
EPS(TTM)74.94
EY36.52%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)9.31
FCFY4.54%
OCF(TTM)14
OCFY6.82%
SpS108.59
BVpS-11.11
TBVpS-25.2
PEG (NY)N/A
PEG (5Y)0.02
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 13.26%
ROE N/A
ROCE 29.95%
ROIC 22.12%
ROICexc 24.28%
ROICexgc 35.92%
OM 13.15%
PM (TTM) 7.89%
GM 39.74%
FCFM 8.57%
ROA(3y)11.57%
ROA(5y)10.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)19.46%
ROIC(5y)17.54%
ROICexc(3y)24.95%
ROICexc(5y)21.23%
ROICexgc(3y)39.22%
ROICexgc(5y)33.95%
ROCE(3y)26.35%
ROCE(5y)23.75%
ROICexgc growth 3Y6.44%
ROICexgc growth 5Y18.1%
ROICexc growth 3Y10.15%
ROICexc growth 5Y21.34%
OM growth 3Y8.36%
OM growth 5Y15.89%
PM growth 3Y4.4%
PM growth 5Y18.04%
GM growth 3Y2.65%
GM growth 5Y2.36%
F-Score6
Asset Turnover1.68
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.5
Debt/EBITDA 2.3
Cap/Depr 142.92%
Cap/Sales 4.32%
Interest Coverage 10.24
Cash Conversion 79.71%
Profit Quality 108.59%
Current Ratio 1.26
Quick Ratio 0.97
Altman-Z 3.83
F-Score6
WACC8.1%
ROIC/WACC2.73
Cap/Depr(3y)164.63%
Cap/Depr(5y)155.41%
Cap/Sales(3y)4.65%
Cap/Sales(5y)4.44%
Profit Quality(3y)105.93%
Profit Quality(5y)111.7%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.92%
EPS 3Y185.54%
EPS 5Y137.97%
EPS Q2Q%-88.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.76%
Revenue growth 3Y7.44%
Revenue growth 5Y7.41%
Sales Q2Q%9.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.29%
EBIT growth 3Y14.04%
EBIT growth 5Y24.72%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.61%
FCF growth 3Y40.12%
FCF growth 5Y16.2%
OCF growth 1Y6.34%
OCF growth 3Y18.89%
OCF growth 5Y13.51%

COCA-COLA CONSOLIDATED INC / COKE Fundamental Analysis FAQ

What is the fundamental rating for COKE stock?

ChartMill assigns a fundamental rating of 5 / 10 to COKE.


What is the valuation status of COCA-COLA CONSOLIDATED INC (COKE) stock?

ChartMill assigns a valuation rating of 4 / 10 to COCA-COLA CONSOLIDATED INC (COKE). This can be considered as Fairly Valued.


Can you provide the profitability details for COCA-COLA CONSOLIDATED INC?

COCA-COLA CONSOLIDATED INC (COKE) has a profitability rating of 7 / 10.


What is the financial health of COCA-COLA CONSOLIDATED INC (COKE) stock?

The financial health rating of COCA-COLA CONSOLIDATED INC (COKE) is 5 / 10.


How sustainable is the dividend of COCA-COLA CONSOLIDATED INC (COKE) stock?

The dividend rating of COCA-COLA CONSOLIDATED INC (COKE) is 4 / 10 and the dividend payout ratio is 15.19%.